A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
Manufacturers are developing platform technologies for personalized CRISPR gene-editing therapies following the Baby KJ case.
A new study reveals experimental drug XL20 crosses the blood-brain barrier to stop toxic TDP-43 clumping in ALS.
To date, the company has raised over $34 million from investors and operates a 15-person team at facilities at Johns Hopkins Medical Campus.
By Pietro Antonio Ciclese, Senior Technical Marketing Engineer, Ambarella The workloads that generate the most commercial ...
Trapped ion quantum computing noise hit a 30-year wall until ETH Zurich researchers built a Penning-trap scanner using a ...
MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the “Company”), a technology service provider, has announced a groundbreaking achievement of great theoretical and engineering significance: its ...
On June 24, 2026, Microsoft’s Digital Crimes Unit (DCU) facilitated the takedown, suspension, and blocking of domains that ...
A fileless malware framework has been abusing Google's Blogspot platform to deliver the PureLog Stealer entirely in memory, letting attackers steal credentials while leaving few traces on disk.
The rise of AI has brought an avalanche of new terms and slang. Here is a glossary with definitions of some of the most ...
The Korean government-funded project will build a brain and AI-controlled full-body exoskeleton for quadriplegic patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results